ImmuneID Announces Close of $50 Million Series A Financing to Develop Precision Immunology Therapeutics June 23, 2021
Stephen Elledge’s Harvard lab Again Proves Fruitful with the Launch of High-Throughput Antibody Startup June 23, 2021
ImmuneID Launches with $17M Financing to Profile and Modulate Immune Response at Unprecedented Scale and Resolution February 18, 2021
